Joseph Jeswin, Karthika Thankamani, Das Valiyathara Rajan Akshay, Raj Victor Stalin
Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research (IISER-TVM), Thiruvananthapuram, India.
Curr Pharm Biotechnol. 2022;23(8):1118-1129. doi: 10.2174/1389201022666210810111716.
Coronaviruses (CoVs) infect a wide range of animals and birds. Their tropism is primarily determined by the ability of the spike protein to bind to a host cell surface receptor. The ongoing outbreak of SARS-CoV-2 inculcates the need for the development of effective intervention strategies.
In this study, we aim to produce pseudotyped coronaviruses of SARS-CoV-1, MERS-CoV, and SARS-CoV-2 and show its applications, including virus entry, neutralization, and screening of entry inhibitors from natural products.
Here, we generated VSV-based pseudotyped coronaviruses (CoV-PVs) for SARS-CoV-1, MERS-CoV, and SARS-CoV-2. Recombinant spike proteins of SARS-CoV-1, MERS-CoV, and SARS-CoV-2 were transiently expressed in HEK293T cells followed by infection with recombinant VSV. High titer pseudoviruses were harvested and subjected to distinct validation assays, which confirms the proper spike pseudotyping. Further, specific receptor-mediated entry was confirmed by antibody neutralization and soluble form of receptor inhibition assay on Vero E6 cells. Next, these CoV-PVs were used for screening of antiviral activity of natural products such as green tea and Spirulina extract.
Medicinal plants and natural compounds have been traditionally used as antiviral agents. In the first series of experiments, we demonstrated that pseudotyped viruses specifically bind to their receptors for cellular entry. SARS-CoV-1 and MERS-CoV anti-sera neutralize SARS-CoV-1-PV and SARS-CoV-2-PV, and MERS-CoV-PV, respectively. Incubation of soluble ACE2 with CoV-PVs inhibited entry of SARS-CoV-1 and SARS-CoV-2 PVs but not MERS-CoV-PV. Also, transient expression of ACE2 and DPP4 in non-permissive BHK21 cells enabled infection by SARS-CoV-1-PV, SARS-CoV-2-PV, and MERS-CoV-PV, respectively. Next, we showed the antiviral properties of known entry inhibitors of enveloped viruses, Spirulina, and green tea extracts against CoV-PVs. SARSCoV- 1-PV, MERS-CoV-PV, and SARS-CoV-2-PV entry was blocked with higher efficiency when preincubated with either green tea or Spirulina extracts. Green tea provided a better inhibitory effect by binding to the S1 domain of the spike and blocking the spike interaction with its receptor.
In summary, we demonstrated that pseudotyped viruses are an ideal tool for studying viral entry, quantification of neutralizing antibodies, and screening of entry inhibitors in a BSL-2 facility. Moreover, green tea might be a promising natural remedy against emerging coronaviruses.
冠状病毒可感染多种动物和鸟类。其嗜性主要由刺突蛋白与宿主细胞表面受体结合的能力决定。目前正在爆发的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)凸显了开发有效干预策略的必要性。
在本研究中,我们旨在制备严重急性呼吸综合征冠状病毒1(SARS-CoV-1)、中东呼吸综合征冠状病毒(MERS-CoV)和SARS-CoV-2的假型冠状病毒,并展示其应用,包括病毒进入、中和以及从天然产物中筛选进入抑制剂。
在此,我们构建了基于水疱性口炎病毒(VSV)的SARS-CoV-1、MERS-CoV和SARS-CoV-2假型冠状病毒(CoV-PVs)。SARS-CoV-1、MERS-CoV和SARS-CoV-2的重组刺突蛋白在人胚肾293T细胞(HEK293T)中瞬时表达,随后用重组VSV感染。收获高滴度的假病毒并进行不同的验证试验,以确认刺突假型化正确。此外,通过抗体中和以及在非洲绿猴肾细胞(Vero E6)上进行受体抑制的可溶性形式试验,证实了特异性受体介导的进入。接下来,这些CoV-PVs用于筛选天然产物如绿茶和螺旋藻提取物的抗病毒活性。
药用植物和天然化合物传统上被用作抗病毒剂。在第一系列实验中,我们证明假型病毒特异性结合其细胞进入受体。SARS-CoV-1和MERS-CoV抗血清分别中和SARS-CoV-1-PV和SARS-CoV-2-PV以及MERS-CoV-PV。将可溶性血管紧张素转换酶2(ACE2)与CoV-PVs孵育可抑制SARS-CoV-1和SARS-CoV-2 PVs的进入,但不抑制MERS-CoV-PV。此外,在非允许性仓鼠肾细胞(BHK21)中瞬时表达ACE2和二肽基肽酶4(DPP4)分别使SARS-CoV-1-PV、SARS-CoV-2-PV和MERS-CoV-PV能够感染。接下来,我们展示了包膜病毒已知进入抑制剂、螺旋藻和绿茶提取物对CoV-PVs的抗病毒特性。当与绿茶或螺旋藻提取物预孵育时,SARS-CoV-1-PV、MERS-CoV-PV和SARS-CoV-2-PV的进入被更高效地阻断。绿茶通过与刺突的S1结构域结合并阻断刺突与其受体的相互作用提供了更好的抑制作用。
总之,我们证明假型病毒是在生物安全二级(BSL-2)设施中研究病毒进入、中和抗体定量以及筛选进入抑制剂的理想工具。此外,绿茶可能是对抗新兴冠状病毒的一种有前景的天然药物。